A pharmacist explains the similarities and differences between these two heart medications Atenolol (brand name Tenormin) and ...

Metoprolol is a beta-blocker approved by the Food and Drug Administration (FDA) to treat several cardiovascular conditions, ...

oval, scored tablets engraved with “A/mY” Metoprolol is a β 1-selective (cardioselective) adrenergic receptor blocking agent that slows the sinus rate and decreases AV nodal conduction.

Metoprolol is a beta-blocker that affects the heart and circulation (blood flow through arteries and veins). Metoprolol is used to treat angina (chest pain) and hypertension (high blood pressure).

Maack et al. [70] recently reported on switching between β blockers (metoprolol and carvedilol) in 68 patients treated with either agent for 1 year who had improved in terms of LVEF and NYHA class.

DENVER, September 12, 2024--Oblong, Inc. (Nasdaq: OBLG) ("Oblong" or the "Company"), the award-winning maker of multi-stream collaboration solutions, today announced that the Company received ...

Metoprolol succinate 25mg, 50mg, 100mg, 200mg; ext-rel caps. Metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent. This preferential effect is not absolute ...

DENVER, September 12, 2024--(BUSINESS WIRE)--Oblong, Inc. (Nasdaq: OBLG) ("Oblong" or the "Company"), the award-winning maker of multi-stream collaboration solutions ...

Oblong's stock surged after the company announced it regained compliance with Nasdaq's minimum bid price rule CEO Peter Holst emphasized the company's exploration of strategic alternatives ...

There is evidence to indicate that full adrenergic blockade by carvedilol improves survival and cardiovascular outcome in patients with heart failure compared with metoprolol treatment ...

DENVER--(BUSINESS WIRE)-- Oblong, Inc. (Nasdaq: OBLG) (“Oblong” or the “Company”), the award-winning maker of multi-stream collaboration solutions, announced today that it has filed an ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...